Gerri Smoluk, PhD

Acute Myeloid Leukemia (AML) Network Manager

Gerri Smoluk is an AML survivor, diagnosed at age 56 in 2016. She is currently in remission following successful completion of two rounds of induction therapy and four rounds of consolidation therapy (high-dose chemo) in 2016. Since her recovery Gerri has been exploring “pretirement” working part-time as a freelance medical writer, traveling, volunteering and exploring what she wants to do in the next phase of her life. Gerri spent most of her career as a drug development scientist. As a trained biochemist, she did graduate work in oncology and has worked on the development of several cancer drugs. She holds a PhD in chemistry from University of California-San Diego and a BSc in biochemistry from McGill University. She also holds a Project Management Professional (PMP®) certification. When Gerri was diagnosed with AML and was moving through treatment, it became her primary research project to determine the best care options for her. She is passionate about patient empowerment and making sure patients have the best tools and resources to enable them to make smart and informed decisions on their treatment plans in concert with their care team. She serves as our AML Network Manager, where she hopes to empower patients and their caregivers to be their own best advocates in their treatment and recovery.